(Q42668601)

4 November 2017

title

Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

4 November 2017

main subject

phase III clinical trial

0 references

0 references

author name string

Brian C Healy

series ordinal

1

1 reference

4 November 2017

David Schoenfeld

series ordinal

2

1 reference

4 November 2017

publication date

1 October 2012

1 reference

4 November 2017

1 reference

4 November 2017

volume

46

1 reference

4 November 2017

issue

4

1 reference

4 November 2017

page(s)

506-511

1 reference

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis

4 November 2017

cites work

1 reference

Phase II/III randomized trial of TCH346 in patients with ALS

21 January 2018

1 reference

A clinical trial of creatine in ALS.

21 January 2018

1 reference

Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial

21 January 2018

1 reference

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

21 January 2018

1 reference

Measures and markers in amyotrophic lateral sclerosis

21 January 2018

1 reference

Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials.

21 January 2018

1 reference

Functional outcome measures as clinical trial endpoints in ALS.

21 January 2018

1 reference

Shared parameter models for the joint analysis of longitudinal data and event times

21 January 2018

1 reference

Random-effects models for longitudinal data

21 January 2018

1 reference

Analysis of left-censored longitudinal data with application to viral load in HIV infection

21 January 2018

1 reference

Mixed models for longitudinal left-censored repeated measures

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.23392

1 reference

4 November 2017

1 reference